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Circulating levels of 7cz-hydroxy-4-cholesten-3-one have been compared with activities of the rate-limiting enzyme in bile acid synthesis. microsomal 
cholesterol 7l-hydroxylase, measured in liver biopsies obtained from patients undergoing surgery for gallstone disease. Some patients were treated 
with cholcstyraminc or bile acids prior to operation in order to alter the feed-back inhibition of the enzyme. The levels of the sterol were similar 
in untreated patients and in patients treated with ursodeoxycholic acid (median concentration 17 and 13 nglml. respectively), and so were the activi- 
ties of the enzyme (median activity 7.0 and 5.5 pmol/min/mg protein, respectively). The sterol levels and enzyme activities were significantly in- 
creased in patients treated with cholestyramine (91 ng/ml and 45 pmol/min/mg protein) and decreased in patients treated with chenodeoxycholic 
acid (< 2.0 ng/ml and 0.7 pmol/min/mg protein). There was a strong positive correlation (r=0.90, P<O.OOOOl) between levels of 7x-hydroxy-4- 
cholesten-3-one in plasma and the activities of cholesterol 7z-hydroxylase in the whole patient group. The results show that analysis of la-hydroxy 
4-cholesten-3-one in plasma is a sensitive and convenient method to determine relative rates of bile acid production in man. 
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1. INTRODUCTION 
Several liver and intestinal diseases are associated 
with a changed production of bile acids. Since bile acids 
are major excretion products of cholesterol [l], such 
changes will affect the turn-over rate of cholesterol in 
the body. Cholesterol 7ar-hydroxylase is considered to 
catalyze the rate-limiting reaction in the biosynthesis of 
bile acids [I], converting cholesterol into 7cr-hydroxy- 
cholesterol. This sterol is then converted into bile acids 
via 7a-hydroxy-4-cholesten-3-one (Fig. 1). Relative 
rates of bile acid production may therefore be evaluated 
in vitro by determination of the activity of cholesterol 
7a-hydroxylase in liver biopsies [2,3]. Since sampling is 
a major obstacle using this assay there is a need for a 
simple method tc determine rates of bile acid synthesis 
in man. Plasma levels of 7a-hydroxycholesterol have 
previously been found to correlate positively to the ac- 
tivities of cholesterol 7cr-hydroxylase but only in pa- 
tients with increased enzyme activity (41. Recently it was 
reported that plasma levels of 7a-hydrcxy-4-cholesten- 
3-one seemed to reflect both an increased and a decreas- 
ed production of bile acids [S]. This conclusion was 
based on a study on patients with predictable changes of 
bile acid synthesis. We have now examined this ap- 
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parent relationship by comparing plasma levels of 7c1- 
hydroxy-4-cholesten-3-one and 7ac-hydroxycholesterol 
with activities of cholesterol 7a-hydroxylase in patients 
treated with bile acids or cholestyramine and the results 
are reported. 
2. MATERIALS AND METHODS 
2.1. Patients and sarwples 
Patients participating in this study had gallstones and were sub- 
jected to a cholecysteclomy at the Huddinge University Hospital. 
None of the patients had signs of diabetes mellitus, hyperlipopro- 
teinemia, or diseases affecting the liver, thyroid and kidney functions. 
Informed consent was obtained from each patient and the study was 
approved by the local Ethical Committee. The patients were divided 
into the following groups: (A) two men and six women (25-65 years 
old, median age 36 years) were untreated prior to surgery and served 
as controls; (B) one man and five women (37-63 years old, median age 
54 years) received ursodcoxycholic acid, 15 mg/kg body weight per 
day, for 3-4 weeks prior to surgery; (C) one man and nine women 
(23-69 years old, median age 49 years) received chenodcoxycholic 
acid, 15 mg/kg body weight per day, for 3-4 weeks before the opcra- 
Lion; (D) one man and seven women (25-67 years old, median age 56 
years) were treated with cholestyraminc (Questran, Bristol) in a dose 
of 8 g lwicc daily 2-3 weeks pre-operatively, The patients were 
hospitalized in the surgical ward l-2 days before the operation. They 
were given the regular hospital diet. Blood samples were collected 
after a 12-h fast just prior to operation. Following ccntrifugation, 
plasma or serum was scparotcd and immcdiatcly stored at - 20°C un- 
til analyzed. The cholecystcctomy was pcrformcd bctwccn 8 a.m. and 
9 a.m. After opening of the abdomen, a 2-3 g liver piccc was cut out 
from the left liver lobe. A small specimen was sent for histological cx- 
nmination. The rest of the biopsy was immediately placed in ice-cold 
hotnogcnizing rncdium and transported IO the laboratory. 
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Fig. 1. A simplified scheme for the conversion of cholesterol (I) into 
bile acids ViU 7o-hydroxycholesterol (IL) and lo- 
hydroxy-4-cholesten-3-one (III). The first reaction is catalyzed by 
cholesterol 7a-hydroxylase. 
2.2. Analytical procedures 
The liver homogenate (10% w/v) was prepared in 50 mM Tris-HCI. 
pH 7.4, containing 50 mM NaCI. 0.3 M sucrose, 10 mM EDTA and 
10 mM DTT. The microsomal fraction was prepared as described 
previously [3]. The microsomal content of protein was determined by 
the method of Lowry et al. [6]. The activity of cholesterol 7~ 
hydroxylase in the microsomal fraction was assayed by isotope 
dilution-mass spectrometry 131. Essentially the same analytical 
method was used for analysis of 7u-hydroxycholesterol in plasma/ 
serum [3,4]. Levels of 7o-hydroxy-4-cholesten-3-one in plasma or 
serum were determined by high-performance liquid chromatography 
with UV detection as described previously [S]. 
2.3. Stalistical analysis 
Statistical evaluation of data included calculation of Spearman’s 
rank correlation coefficient and Kolmogorov-Smirnov’s two sample 
test. The median and interquartil range were used as measures of cen- 
tral tendency and variation, respectively [7]. 
3. RESULTS 
The activity of cholesterol 7c+hydroxylase in liver 
tissue was compared with the level of 7cy-hydroxy-4- 
cholesten-3-one in plasma obtained from patients 
undergoing surgery for gallstone disease. Some patients 
were treated with cholestyramine or bile acids prior to 
operation in order to alter bile acid production by 
affecting the feed-back inhibition on cholesterol 7cr-hy- 
droxylase. The results are summarized in Table I. 
As expected from previous studies, treatment with 
cholestyramine resulted in an increased and chenodeo- 
xycholic acid in a decreased activity of cholesterol 7o- 
hydroxylase [4]. Treatment with ursodeoxycholic acid 
had no apparent effect on the enzyme activity. Changes 
in the levels of 7ol-hydroxy-4-cholesten-3-one paralleled 
those of the enzyme activity. A significant elevation of 
levels was seen in plasma from patients treated with 
cholestyramine (PC 0.001). The levels were subnormal 
(P<O.OOl) and often below the detection level in 
plasma from patients treated with chenodeoxycholic 
acid, whereas patients treated with ursodeoxycholic 
acid had normal levels. There was no overlap between 
levels of the controls and those of patients treated with 
cholestyramine or chenodeoxycholic acid. The correla- 
tion between levels of 7ar-hydroxy-4-cholesten-3-one 
and corresponding activities of cholesterol 7a-hydroxy- 
lase for the entire patient group is illustrated in Fig. 2 
and was highly significant (r, = 0.90, P~O.00001). 
However, with the exception of values for patients 
treated with ursodeoxycholic acid, there was no correla- 
tion between sterol levels and enzyme activities within 
each group. Whether this was due to the limited number 
of patients within the groups or to other factors is not 
known. 
For reasons of comparison, plasma levels of 7o- 
hydroxycholesterol were also determined. As expected, 
the levels of 7ol-hydroxycholesterol were elevated in pa- 
tients treated with cholestyramine [4]. However, in con- 
trast to those of 7a-hydroxy-4-cholesten-3-one, levels 
were not decreased in patients treated with chenodeox- 
ycholic acid (Table I). 
4. DISCUSSION 
Determination of rates of bile acid synthesis is impor- 
tant as a diagnostical aid in liver and.gastrointestinal 
diseases and during dietary, hormonal and pharmaco- 
logical manipulations of plasma cholesterol levels. 
However, available methods such as isotope-dilution 
techniques, analysis of fecal bile acid excretion or assay 
of the rate-limiting enzyme, cholesterol 7a-hydroxylase 
Table I 
Concentrations of 7n-hydrosy-4-cholesten-3-one in plasma and activities of hepatic microsomal 
cholesterol la-hydrosylase in untreated patients and patients treated with ursodeoxycholic acid, 
chcnodeoxycholic acid, or cholestyramine. The corresponding concentrations of 7o-hydroxycholesterol 
are shown for comparison, 
p-...-- 
Patients” 111’ Activities of cholesterol Concentrations in plasma’ (ng/ml) 
7a-hydroxylasec 
(pniol/min/mg protein) 
7a-hydroxy-4- ‘lo-hydroxy- 
-cholcsten-3-one cholesterol 
Untreated 8 7.0:5.5-l I. I 17: IO-2G 17:ll-20 
Treated with: 
Ursodeoxycholic acid 6 5.514.2-9.8 13:10-24 12:8.0-17 
Chenodcoxycholic acid 10 0.7:<0.1-2.1d e2.0: < I.&2.2d 7.0:2.0-25 
Cholestyraminc 8 45:32-50” 9l:G2-140d 85:52-127J 
“Details 011 patients and doses arc given in section 2. 
“Number of patients. 
‘Values arc cxprcsscd as mctli~n: lower quartil-upper quartil. 
“Median significantly diffcrcnt from that of thr untrcatrtl group (P<O.OOl), 
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Fig. 2. The relationship between concentrations of 7u- 
hydroxy-4-cholesten-3-one in plasma and activities of cholesterol 7a- 
hydroxylase in liver iissue from untreated patients (0) and patients 
treated with ursodeoxycholic acid ( A ), chenodeoxycholic acid ( A ) 
and cholestyramine (0). 
in liver biopsies [2,3] are complicated and time- 
consuming. 
This study shows that there is a strong positive cor- 
relation between the hepatic enzyme activity and the 
plasma level of 7a-hydroxy-4-cholesten-3-one. Analysis 
of this sterol may therefore be a convenient method for 
evaluating the relative rate of bile acid synthesis in 
humans. Its precursor 7a-hydroxycholesterol has 
previously been proposed to serve this purpose [4], but 
this compound only reflects normal and increased en- 
zyme activities. 
Also from a methodological point of view, measure- 
ment of 7cY-hydroxy-4-cholesten-3-one has merits as 
compared to that of 7a-hydroxycholesterol. The former 
compound can be accurately determined with a simple 
HPLC method [5] whereas analysis of 7a-hydroxy- 
cholesterol requires more sophisticated methods [4]. 
Furthermore 7a-hydroxycholesterol can be formed by 
auto-oxidation of cholesterol and may be artifactually 
produced in the handling of plasma samples. This is not 
the case with 7a-hydroxy-4-cholesten-3-one [8],Thus, it 
may be concluded that 7a-hydroxy-4-cholesten-3-one is 
a better marker for the activity of cholesterol 
7cY-hydroxylase than 7a-hydroxycholesterol. 
Theoretically the level of 7a-hydroxy-4-cholesten-3- 
one in plasma should be dependent upon several factors 
Oiki tkX C.S.S.,. __ h 1 +-ml ?+hydroxylase activity, e.g. sub- 
strate availability, activity of the hepatic Whydroxy- 
steroid-A’-dehydrogenase, rate of diffusion/secretion 
of the sterol into blood and rate of metabolism/elimi- 
nation. These factors may vary between patients and 
could possibly contribute to the poor correlation be- 
tween sterol levels and enzyme activities observed 
within the patient groups. In spite of this, levels of 7a- 
hydroxy-4-cholesten-3-one in plasma are normally 
within a relatively narrow range (6-30 ng/ml) [5], sug- 
gesting that such factors are relatively constant. 
It should be emphasized that circulating levels of 7a- 
hydroxy-4-cholesten-3-one do not necessarily reflect the 
total production of bile acids in man under all condi- 
tions. Thus a portion of bile acids can be formed via 
pathways by-passing cholesterol 7a-hydroxylase as the 
rate-limiting step [9]. The relative importance of such 
pathways is not known at present. 
In conclusion, the strong correlation between cir- 
culating levels of 7a-hydroxy-4-cholesten-3-one a dac- 
tivities of cholesterol 7a-hydroxylase in human liver 
shows that analysis of 7ar-hydroxy-4-cholesten-3-one 
can be used in studies on bile acid synthesis in man. 
Since plasma samples can be collected with short time 
intervals, the method is particularly attractive to use 
when rapid changes in the activity of the cholesterol 7a- 
hydroxylase are to be studied in vivo. 
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